These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7587028)

  • 41. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery.
    Anderson G; Boldiston C; Woods S; O'Brien P
    Arch Surg; 1996 Jul; 131(7):744-8. PubMed ID: 8678775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients.
    Parrish AG
    S Afr Med J; 1998 Sep; 88(9):1046, 1048; author reply 1050-1. PubMed ID: 9798485
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical role of cefixime in community-acquired infections.
    Chemotherapy; 1998 Sep; 44 Suppl 1():35-8. PubMed ID: 9797423
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical outcomes and cost minimization with an alternative dosing regimen for meropenem in a community hospital.
    Patel GW; Duquaine SM; McKinnon PS
    Pharmacotherapy; 2007 Dec; 27(12):1637-43. PubMed ID: 18041884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative study of single-dose cefotaxime and multiple doses of cefoxitin and cefazolin as prophylaxis in gynecologic surgery.
    Campillo F; Rubio JM
    Am J Surg; 1992 Oct; 164(4A Suppl):12S-15S. PubMed ID: 1443353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefotaxime--a clinical study.
    McKendrick MW; Geddes AM; Wise R; Andrews JA
    J Antimicrob Chemother; 1981 Apr; 7(4):405-14. PubMed ID: 6265425
    [No Abstract]   [Full Text] [Related]  

  • 49. The in vitro activity of cefotaxime versus bacteria involved in selected infections of hospitalized patients outside of the intensive care unit.
    Doern GV
    Diagn Microbiol Infect Dis; 1995; 22(1-2):13-7. PubMed ID: 7587027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children.
    McCracken GH; Nelson JD; Kaplan SL; Overturf GD; Rodriguez WJ; Steele RW
    Pediatr Infect Dis J; 1987 Jun; 6(6):501-5. PubMed ID: 3615064
    [No Abstract]   [Full Text] [Related]  

  • 52. [Amoxycillin/potassium clavulanate in inpatients with bronchopulmonary infections].
    Nonikov VE; Konstantinova TD; Lenkova NI; Minaev VI; Ritchik LA
    Antibiot Khimioter; 1997; 42(10):15-8. PubMed ID: 9412397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of cefotaxime in the treatment of surgical infections.
    Wittmann DH
    Diagn Microbiol Infect Dis; 1995; 22(1-2):173-82. PubMed ID: 7587036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
    Sen RA; Keaney MG; Ganguli LA
    J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576
    [No Abstract]   [Full Text] [Related]  

  • 55. Cefepime versus cefotaxime in the treatment of lower respiratory tract infections.
    Barckow D; Schwigon CD
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():187-93. PubMed ID: 8150762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ceftizoxime compared with cefamandole for treatment of soft tissue infections.
    Mills J; Slutkin G; Klein D; Schecter W
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():273-9. PubMed ID: 6296020
    [No Abstract]   [Full Text] [Related]  

  • 57. A comparative study of cefotaxime sodium versus a combination of cefapirin and gentamicin in the prophylactic treatment of patients undergoing cholecystectomy.
    Ker CG; Hou MF; Chen JS; Lee KT; Sheen PC; Akbary MA
    Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):711-5. PubMed ID: 2695726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical studies of cefotaxime, administration in intravenous drip infusion, for infectious diseases in the field of obstetrics and gynecology (author's transl)].
    Hagiwara K
    Jpn J Antibiot; 1981 Apr; 34(4):500-6. PubMed ID: 6270398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical efficacy of cefotaxime in two different periods.
    Peralta S; Vitale B; Scarsi C; D'Aiello G; Rotondo G; Delle Vedove G; Rini GB
    J Chemother; 1989 Jul; 1(4 Suppl):648-9. PubMed ID: 16312574
    [No Abstract]   [Full Text] [Related]  

  • 60. Cefotaxime in the 90's: A workshop for appropriate broad-spectrum cephalosporin utilization.
    Diagn Microbiol Infect Dis; 1995; 22(1-2):1-247. PubMed ID: 7587020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.